Differential Expression of Pleiotrophin and Midkine in Advanced Neuroblastomas

Akira Nakagawara, Jeffrey Milbrandt, Takashi Muramatsu, Thomas F. Deuel, Huaqing Zhao, Avital Cnaan, Garrett M. Brodeur

Research output: Contribution to journalArticlepeer-review

204 Scopus citations

Abstract

Pleiotrophin (PTN) and midkine (MK) are members of a new family of neurotrophic factors whose expression is developmentally regulated. PTN also transforms NIH 3T3 cells, and MK is mitogenic to certain cell lines. Neuroblastomas are tumors derived from neural crest cells, and recent studies have revealed that the biology of these tumors is at least partly regulated by neurotrophic factors and their receptors. To examine the expression of PTN and MK in neuroblastoma, we analyzed their mRNA expression in 72 primary neuroblastomas and 11 neuroblastoma cell lines as well as other tissues and cell lines. PTN is highly expressed in favorable neuroblastomas (stages I, II, and IV-S, n = 44), whereas it is expressed at a significantly lower level in advanced tumors (stages III and IV, n = 28, P = 0.003). PTN is not expressed in either aggressive neuroblastomas with N-myc amplification or in neuroblastoma cell lines. Moreover, the expression pattern of PTN was similar to that of TRK-A, the high affinity receptor for nerve growth factor, in that it is correlated with a favorable prognosis (P < 0.004). In contrast, MK is highly expressed in almost all primary neuroblastomas and cell lines and showed no correlation with disease stage or N-niyc amplification. These results suggest that differential expression of PTN and MK may have an important role in regulating growth and differentiation of neuroblastomas.

Original languageEnglish
Pages (from-to)1792-1797
Number of pages6
JournalCancer research
Volume55
Issue number8
StatePublished - Apr 15 1995

Fingerprint

Dive into the research topics of 'Differential Expression of Pleiotrophin and Midkine in Advanced Neuroblastomas'. Together they form a unique fingerprint.

Cite this